Surgery Partners (SGRY) Stock: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$15.90
0.50 (3.25%)
▲
5d:
+7.65%
30d:
+9.2%
90d:
+1.08%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 09, 2026
16d
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SGRY shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SGRY shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.52
Based on -8.0% avg growth
INTRINSIC VALUE TODAY
$2.80
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $15.90, which is considered extended relative to its 30-day fair value range of $13.48 to $14.99. From a valuation perspective, the stock is trading at a premium (Forward PE: 56.8) compared to its historical average (27.6). At these levels, the market is pricing in 27.2% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $16.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: SGRY scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.82 (+18.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SGRY is in a downtrend. The price is approaching resistance at $16.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: SGRY scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.82 (+18.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.48 -
$14.99
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.4%
Protect Your Profits
Holding SGRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.1% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading below Wall St target ($18.82)
- BEARISH: Market expects 27.2% growth - appears too optimistic based on history
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$13.48 -
$14.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.61
Resistance Level
$16.00
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
56.79
Wall Street Target
$18.82
(+18.4%)
Revenue Growth (YoY)
2.7%
Profit Margin
-2.6%
Valuation Premium vs History
+27.2% premium
PE vs Historical
56.8 vs 27.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+27.2%
(market-implied from PE analysis)
1-Year Target
$20.22
(+27%)
2-Year Target
$25.73
(+62%)
3-Year Target
$32.72
(+106%)
3-Yr Target (if PE normalizes)
(PE: 57→28)
PE COMPRESSION
$15.90
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 56.8, Growth: -20.0%)
$11.59
(+-27%)
Base:
(SPY PE: 19.9, Growth: -20.0%)
$4.05
(-75%)
Bear:
(PE: 16.9, Growth: -20.0%)
$3.45
(-78%)
Share & Embed Analysis
Last updated: October 22, 2026 7:28 PM ET
Data refreshes hourly during market hours. Next update: 8:28 PM
Data refreshes hourly during market hours. Next update: 8:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 54 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 50 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 60 HOLD |
|
GRDN
Guardian Pharmacy Servic… |
STRONG BUY
7 analysts |
$50 | 60 BUY |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
